Laboratorio Reig Jofre, S.A. (LON:0RB1)

Market Cap	175.64M -12.7%
Revenue (ttm)	290.81M +0.3%
Net Income	5.97M +8.7%
EPS	n/a
Shares Out	n/a
PE Ratio	29.41
Forward PE	12.58
Dividend	0.02 (0.78%)
Ex-Dividend Date	May 21, 2026

Volume	5
Open	2.620
Previous Close	2.560
Day's Range	2.610 - 2.620
52-Week Range	2.340 - 2.930
Beta	0.94
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 13, 2026

About Laboratorio Reig Jofre

Laboratorio Reig Jofre, S.A., a pharmaceutical company, researches, develops, manufactures, and markets pharmaceutical products, raw materials, biotechnological products, nutritional supplements, health products, medical devices, cosmetics, parapharmaceuticals, food, and other products. Its products also include pharmaceutical technologies products, such as antibiotics, and injectables and other products; specialty pharmacare products, which include skin, hair, nails, joint health and pain, and women’s health; and food supplements under the For...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1929
• Employees: 1,512
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0RB1

Financial Performance

In 2025, Laboratorio Reig Jofre's revenue was 336.68 million, a decrease of -1.37% compared to the previous year's 341.37 million. Earnings were 5.02 million, a decrease of -51.64%.

Financial numbers in EUR

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Nov 10, 2026

Data Sources Report a data error